These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative antitumor effects of peptichemio and other alkylating agents. Schmid FA, Banks SE, Stock CC. Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145 [No Abstract] [Full Text] [Related]
4. The need for additional alkylating agents. Connors TA. Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691 [No Abstract] [Full Text] [Related]
5. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations]. Kulik GI. Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230 [No Abstract] [Full Text] [Related]
7. 3-N,N-bis(2-chloroethylamino)p-toluic acid, a new cytostatic drug active in cancer. Dobre V, Maltezeanu G. Cancer Chemother Rep; 1970 Oct; 54(5):319-23. PubMed ID: 5514620 [No Abstract] [Full Text] [Related]
8. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies. Sugiura K, Merker PC. Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213 [No Abstract] [Full Text] [Related]
9. Chemotherapy of breast cancer. Hall TC. Clin Obstet Gynecol; 1968 Jun; 11(2):401-15. PubMed ID: 4972174 [No Abstract] [Full Text] [Related]
10. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour. Ujházy V. Neoplasma; 1969 Jun; 16(4):467-8. PubMed ID: 5344233 [No Abstract] [Full Text] [Related]
12. [The effect of zymosan on the toxicity and activity of various antitumor preparations]. Veksler IG. Vopr Onkol; 1966 Jun; 12(8):80-6. PubMed ID: 4972211 [No Abstract] [Full Text] [Related]
13. [Selectivity of the antitumor action of 2 alkylating compounds with different carrier structures]. Astardzhieva Z, Stoichkov I. Eksp Med Morfol; 1988 Jun; 27(2):14-7. PubMed ID: 3168903 [No Abstract] [Full Text] [Related]
14. [Therapy of lymphogranulomatosis]. Hennemann HH. Dtsch Med Wochenschr; 1969 Mar 28; 94(13):664-6. PubMed ID: 4180636 [No Abstract] [Full Text] [Related]
15. Experimental study on the antitumoral activity of some N-mustards derivatives of the L-asparagic acid. Năstasă V, Sunel V, Dăneţ D, Dăneţ R. Rev Med Chir Soc Med Nat Iasi; 1983 Mar 28; 87(4):619-22. PubMed ID: 6676886 [No Abstract] [Full Text] [Related]
17. Combination chemotherapy in isolation perfusion: use of mitotic inhibitors in pretreatment of V x 2 carcinoma undergoing isolation perfusion with alkylating agents. Mashima Y, Nagatsu M, Lambert A. Cancer Chemother Rep; 1972 Apr 28; 56(2):175-81. PubMed ID: 5043225 [No Abstract] [Full Text] [Related]
18. [Role of immunity in the action of sarcolysine and other preparations]. Syrkin AB, Solenov VN, Bodiagin DA, Zaĭtseva LA. Vestn Akad Med Nauk SSSR; 1971 Apr 28; 26(3):55-9. PubMed ID: 5581445 [No Abstract] [Full Text] [Related]
19. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Geran RI, Congleton GF, Dudeck LE, Abbott BJ, Gargus JL. Cancer Chemother Rep 2; 1974 Dec 28; 4(4):53-87. PubMed ID: 4447935 [No Abstract] [Full Text] [Related]
20. [Vitamin B-12 in the chemotherapy of experimental tumors]. Bulkina ZP, Poliak NR. Vopr Onkol; 1968 Dec 28; 14(4):70-5. PubMed ID: 4969819 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]